To join this virtual session, please use the following link: https://us02web.zoom.us/j/88940617831
Neuromuscular disease specialists, neurologists, and other healthcare providers who manage patients with CIDP.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an independent educational grant from Sanofi.
Virtual Session
For all CE inquiries or special needs, please contact admin@academiccme.com.
Examine the pathophysiology of CIDP and the current standards of care and unmet needs for patients with CIDP.
Evaluate the current clinical trial data for new and emerging complement inhibitor therapeutics for the long-term management of patients with CIDP.
Discuss best practices for applying complement inhibitor therapeutics for their potential role when individualizing treatment plans to improve outcomes in patients with CIDP.
To join this virtual session, please use the following link: https://us02web.zoom.us/j/88940617831